Comments
Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Galantamine tablets. Galantamine tablets are the generic version of Ortho McNeil Janssen Pharmaceutical Inc's Razadyne tablets. They are indicted for the treatment of mild to moderate dementia of the Alzheimer's type. The product had a market size of approximately $41 million for the 12 months ending September 2010. The drug would be launched shortly, the Hyderabad-based company said in a release on Wednesday.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.